Fresenius SE & Co. (OTCMKTS:FSNUY) Shares Gap Down – What’s Next?

Fresenius SE & Co. (OTCMKTS:FSNUY) gapped down before the market opened on Thursday . The stock had previously closed at $15.13, but opened at $14.35. Fresenius SE & Co. shares last traded at $14.35, with a volume of 3,698 shares traded.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Morgan Stanley reaffirmed an “overweight” rating on shares of Fresenius SE & Co. in a research note on Monday, December 15th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Fresenius SE & Co. in a report on Monday, October 27th. Two investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy”.

Fresenius SE & Co. Trading Down 4.7%

The business has a fifty day moving average of $14.17 and a 200-day moving average of $13.89. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.99 and a current ratio of 1.26. The company has a market capitalization of $32.21 billion, a P/E ratio of 26.22 and a beta of 0.76.

Fresenius SE & Co. (OTCMKTS:FSNUY) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.23 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.02. Fresenius SE & Co. had a net margin of 5.26% and a return on equity of 9.72%. The firm had revenue of $6.29 billion for the quarter, compared to analyst estimates of $6.38 billion. Analysts anticipate that Fresenius SE & Co. will post 0.79 earnings per share for the current fiscal year.

Fresenius SE & Co. Company Profile

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.